DO LACTOBACILLI CHALENGE GARDNERELLA VAGINALIS BIOFILMS?
Abstract
Bacterial vaginosis (BV) is a highly prevalent vaginal dysbiosis that has been linked to adverse pregnancy outcomes and enhanced transmission of sexually transmitted infections (STIs). Key characteristics of the disease process are thought to be depletion of vaginal Lactobacillus and overgrowth of anaerobes (often dominated by G.vaginalis) and a pH > 4.5. Currently, is consensual that BV also involves the presence of a dense, structured and polymicrobial biofilm, primarily constituted by G.vaginalis clusters, strongly adhered to the vaginal mucosal surface. Biofilms are communities of microorganisms attached to a surface and encased in a selfproduced polymeric matrix. Reduction of the adhesive and biofilm forming capacity activity of G. vaginalis bacteria by Lactobacillus strains is a well-known and desired effect of strains for potential vaginal probiotic application. The objectives of the present study were to evaluate in vitro the effect of Lactobacillus on biofilm production by different species of G.vaginalis isolated from women with bacterial vaginosis (BV). A total of 36 isolates from women with BV identified as G.vaginalis were tested for their biofilm-forming capacity as monocultures and in bacterial coculture with confirmed non-biofilm producing strain of Lactobacillus, in a ratio of 1:1 by microtiter plate assay. Lactobacillus strain in our study was capable of interfering with the growth of G. vaginalis biofilms to different degrees. According to the criteria for biofilm-forming ability, after 24-h incubation 25%, 28% and 22% of Gardnerella monocultures were strong, moderate and weak biofilm producers, compared to 5.5%, 14% and 33.5% of Gardnerella+Lactobacillus cocultures, respectively. Our results indicate the potential of lactobacilli as probiotics, since they effectively reduced the adheration and biofilm formation of the tested Gardnerella species which is a well-known and desired effect of strains for potential vaginal probiotic application.
Key words: biofilms, resistance, lactobacilli, genital.
References
Challenges to current therapies and emerging solutions. Front Microbiol. 2015;6:1528.
2. Huang B, Fettweis JM, Brooks JP, Jefferson KK, Buck GA. The changing landscape of the vaginal microbiome.
Clin Lab Med. 2014;34:747–61.
3. SE Hawes, SL Hillier, J Benedetti, et al.Hydrogen peroxide-producing lactobacilli and acquisition of vaginal
infections. J Infect Dis, 174 (1996), pp. 1058-1063
4. V Redondo-Lopez, RL Cook, JD Sobel. Emerging role of lactobacilli in the control and maintenance of the
vaginal bacterial microflora. Rev Infect Dis, 12 (1990), pp. 856-872
5. A Aroutcheva, D Gariti, M Simon, et al.Defense factors of vaginal lactobacilli. Am J Obstet Gynecol, 185 (2001),
pp. 375-379
6. Hillier SL, Krohn MA, Rabe LK, Klebanoff SJ, Eschenbach DA: The normal vaginal flora, H2O2-producing
lactobacilli, and bacterial vaginosis in pregnant women. Clin Infec Dis. 1993, 16: S273-81.
7. Thorsen P, Jensen IP, Jeune B, Ebbesen N, Arpi M, Bremmelgaard A, Moller BR: Few microorganisms associated
with bacterial vaginosis may constitute the pathologic core: A population-based microbiologic study among
3596 pregnant women. Am J Obstet Gynecol. 1998, 178: 580-587. 10.1016/S0002-9378(98)70442-9.
8. Sobel, J. D. (2000). Bacterial vaginosis. Annu. Rev. Med. 51, 349–356. doi: 10.1146/annurev.med.51.1.349
9. van Oostrum N, De Sutter P, Meys J, Verstraelen H. Risks associated with bacterial vaginosis in infertility
patients: A systematic review and meta-analysis. Hum Reprod. 2013;28:1809–15.
10. Koumans, E. H., Sternberg, M., Bruce, C., McQuillan, G., Kendrick, J., Sutton, M., et al. (2007). The prevalence of
bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and
reproductive health. Sex. Transm. Dis. 34, 864–869. doi: 10.1097/OLQ.0b013e318074e565.
11. T. T. Suehiro, N. Malaguti, E. Damke et al., “Association of human papillomavirus and bacterial vaginosis with
increased risk of high-grade squamous intraepithelial cervical lesions,†International Journal of Gynecological
Cancer, vol. 29, no. 2, pp. 242–249, 2019.
12. C. Chehoud, D. J. Stieh, A. G. Bailey et al., “Associations of the vaginal microbiota with HIV infection, bacterial
vaginosis, and demographic factors,†AIDS, vol. 31, no. 7, pp. 895–904, 2017.
13. Schwebke JR, Muzny CA, Josey WE. Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: a
conceptual model. J Infect Dis. 2014;210:338–43.
14. Swidsinski, A., Mendling, W., Loening-Baucke, V., Ladhoff, A., Swidsinski, S., Hale, L. P., et al. (2005). Adherent
biofilms in bacterial vaginosis. Obstet. Gynecol. 106, 1013–1023.
15. Heukelekian H, Heller A. Relation between food concentration and surface for bacterial growth. J Bacteriol.
1940; 40:547-58.
16. Lewandowski Z. Structure and function of biofilms. In: Evans LV, editor. Biofilms: recent advances in their
study and control. Amsterdam: Harwood Academic Publishers; 2000. p. 1-17.
17. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000;46;S47-S52.
18. Thien-Fah CM, George AoO'T. Mehanismas of biofilm resistance to antimicrobial agents. Trends in
microbiology 2001 January;
19. Patterson, J. L., Girerd, P. H., Karjane, N. W., and Jefferson, K. K. (2007). Effect of biofilm phenotype on
resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am. J. Obstet. Gynecol. 197, e1–e7.
20. Swidsinski, A., Mendling, W., Loening-Baucke, V., Swidsinski, S., Dörffel, Y., Scholze, J., et al. (2008). An
adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral
metronidazole. Am. J. Obstet. Gynecol. 198, 97.e1–e6.
21. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain.
Antimicrobial Agents and Chemotherapy. 1987;31:1231–1233.
22. Aroutcheva AA, Simoes JA, Faro S. Defense factors of vaginal lactobacilli.Infect Dis Obstet Gynecol. 2001;
9(1):33-9.
23. Reid G, Burton J. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect. 2002 Mar;
4(3):319-24.
24. Christensen GD, Simpson WA, Bismo AL, Beachery EH. The adherence of the slime-producing strains of
Staphylococcus epidermidis to smooth surfaces. Infect immune. 1982;37:318–26.
25. Braga PC, Dal SM, Culici M, Spallino A. Inhibitory activity of thymol on native and mature Gardnerella vaginalis
biofilms: in vitro study. Arzneimittelforschung 2010;60(11):675–81.
26. Stepanovic, S.; Vukovic, D.; Hola,V.; Bonaventura, G.; Djukic, S.; Irkovic, I.C.; Ruzicka, F. Quantification of
biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of
biofilm production by staphylococci. APMIS 2007; 71 (5), 687-690.
27. Castro, J., Machado, D. & Cerca, N. Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial
Vaginosis biofilms: the impact of other vaginal pathogens living as neighbors. ISME J 13, 1306–1317 (2019).
28. Hardy L, Jespers V, Dahchour N, Mwambarangwe L, Musengamana V, Vaneechoutte M, et al. Unravelling the
bacterial vaginosis-associated biofilm: a multiplex Gardnerella vaginalis and Atopobium vaginae fluorescence
in situ hybridization assay using peptide nucleic acid probes. PLoS ONE. 2015;10:e0136658.
29. Machado A, Cerca N. Influence of biofilm formation by Gardnerella vaginalis and other anaerobes on
bacterial vaginosis. J Infect Dis. 2015;212:1856–61.
30. Hardy L, Jespers V, Van den Bulck M, Buyze J, Mwambarangwe L, Musengamana V, et al. The presence of the
putative Gardnerella vaginalis sialidase A gene in vaginal specimens is associated with bacterial vaginosis
biofilm. PLoS ONE. 2017;12:e0172522.
31. Jung HS, Ehlers MM, Lombaard H, Redelinghuys MJ, Kock MM. Etiology of bacterial vaginosis and
polymicrobial biofilm formation. Crit Rev Microbiol. 2017;43:651–67.
32. Swidsinski A, Loening-Baucke V, Mendling W, Dörffel Y, Schilling J, Halwani Z, et al. Infection through
structured polymicrobial Gardnerella biofilms (StPM-GB). Histol Histopathol. 2013;29:567–87.
33. Tamrakar, R., Yamada, T., Furuta, I. et al. Association between Lactobacillus species and bacterial vaginosis-
related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect Dis 7, 128 (2007).
34. Saunders S, Bocking A, Challis J, Reid G. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms.
Colloids Surf B Biointerfaces. 2007;55(2):138-142.
35. Hütt P., Lapp E., Štšepetova J., et al. Characterisation of probiotic properties in human vaginal lactobacilli
strains. Microbial Ecology in Health & Disease. 2016;27:1–9.
36. Atassi F, Brassart D, Grob P, Graf F, Servin AL. Lactobacillus strains isolated from the vaginal microbiota of
healthy women inhibit Prevotella bivia and Gardnerella vaginalis in coculture and cell culture. FEMS Immunol
Med Microbiol. 2006;48(3):424-432.
37. Martinez RC, Franceschini SA, Patta MC, et al. Improved cure of bacterial vaginosis with single dose of
tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind,
placebo-controlled trial.
